OBJECTIVES: The majority of cardiac device recipients are routinely followed. Implantable Cardioverter Defibrillators (ICDs) devices must be systematically and continually monitored, with follow-up frequency adjusted for the patient’s underlying medical condition, device-related issues, and patient preferences. In México, in CMN-IMSS La Raza, the current implant rate for ICD is 5 per million (equating to 30 new implants per year) and every year an average of 180 patients implanted with ICD are attending follow-up visits at La Raza hospital in Mexico. This simulation provides evidence to support the use of remote follow up and monitoring of ICDs via the CareLink Network as an alternative to follow-up consultations in attending an outpatient clinic setting. METHODS: The simulation considers patients implanted with ICD (without CareLink) will on average require 4 in-clinic follow-up consultations per year whilst those with CareLink will only require 1 in-clinic follow-up consultation (4-6 weeks post implant) and 3 remote follow-up consultations. Reviewing patient data provided via the CareLink Network (remote monitoring consultation) requires an average 8.4 minutes of cardiac physiologist time compared to 25.8 minutes for an in–clinic follow-up consultation.  RESULTS: For each patient per year the introduction of a remote monitor to support device follow-ups, lead to a reduction in cardiac physiologist time of 52.2 minutes equivalent to $17,970 MXP ($30,686 MXP without CareLink versus $12,716 MXP on CareLink). The cost of a cardiac physiologist time is $2630.00 MXP (per hour) equating to MXP 368.20 per remote follow-up versus $1130.90 MXP per in-clinic follow-up. CONCLUSIONS: The use of CareLink can potentially generate economic benefits for the health professional, institution, health system and the patient.